Olga Brawman-Mintzer to Antidepressive Agents
This is a "connection" page, showing publications Olga Brawman-Mintzer has written about Antidepressive Agents.
Connection Strength
0.683
-
New trends in the treatment of anxiety disorders. CNS Spectr. 2004 Aug; 9(8 Suppl 7):19-27.
Score: 0.210
-
The pharmacologic treatment of depression: is gender a critical factor? J Clin Psychiatry. 2002 Jul; 63(7):610-5.
Score: 0.182
-
A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults. J Clin Psychopharmacol. 2018 Aug; 38(4):336-343.
Score: 0.138
-
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies. J Affect Disord. 2016 Dec; 206:151-160.
Score: 0.120
-
Anxious depression. J Clin Psychiatry. 1998; 59 Suppl 18:10-7.
Score: 0.033